Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

• Tempus AI reported peer-reviewed results in Genetics in Medicine Open on Ambry’s ExomeReveal RNA testing to clarify uncertain exome findings.
• The study reviewed nearly 2,000 variants over five years, flagging a subset for follow-up RNA testing based on likely splicing impact.
• Among participants with variants initially labeled uncertain, targeted RNA testing reclassified some results to support a definitive diagnosis.
• The authors concluded RNA integration is practical for selected cases, outlining criteria that could broaden adoption in clinical labs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260609624084) on June 09, 2026, and is solely responsible for the information contained therein.